In-vitro activity of ofloxacin against isolates of Neisseria gonorrhoeae.
A total of 1186 clinical isolates of Neisseria gonorrhoeae were tested for in-vitro disc susceptibility to ofloxacin, one of the new generation of fluorinated quinolones. All isolates appeared susceptible. Minimum inhibitory concentrations were determined for a random sample of 122 strains and all were equal to or less than 0.02 mg/l.
D005260:Female; D006801:Humans; D008297:Male; D008826:Microbial Sensitivity Tests; D009344:Neisseria gonorrhoeae / Q000187:drug effects*; D015242:Ofloxacin / Q000494:pharmacology*
D015242:Ofloxacin